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doi:10.1016/j.ejvs.2009.06.013Abstract Objectives: In our series of patients with congenital vascular malformations (CVMs)
we investigate the preoperative factors for predicting major haemorrhage at surgery and
propose an algorithm for their surgical management.
Design: This is a partly prospective case series of patients with severe symptoms/complica-
tions due to CVMs.
Materials and methods: Data were collected on 73 consecutive procedures in 41 patients with
CVMs from 1992 to 2006 at a large university hospital and the association of following factors
with blood loss during the procedure were investigated: type of procedure, possibility of prox-
imal tourniquet use, lesion flow characteristics, previous history of major haemorrhage with
CVM surgery, platelet counts and length of hospital stay.
Results: Significantly higherblood losswas associatedwith debulking surgery (pZ 0.006) andwith
previous history of major haemorrhage during CVM surgery, (pZ 0.041). Blood loss was higher in
lesionswhereproximal tourniquetapplicationwasnotpossible (pZ 0.093).High-flowlesionswere
not strongly associated with major blood loss (pZ 0.288). Major blood loss (>2 l) occurred in 16
(20.8%) procedures performed on 11 (26.2%) patients, but this did not prolong hospital stay.
Conclusion: Surgery can potentially improve morbidity/mortality in patients with life/limb-
threatening complications or severe symptoms due to CVMs, providing they aremanaged inmulti-
disciplinary specialised centres.
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ty for Vascular Surgery. PublisheCongenital vascular malformations (CVMs) are associated
with morbidity and cardiac mortality, and only few lesions
can be completely cured. Many classifications of CVMs have
been elaborated. The Hamburg classification is accepted as
the standard,1 and CVMs are sub-classified according to the
embryonal stage at which the developmental arrestd by Elsevier Ltd. All rights reserved.
Surgery on Vascular Malformations and How to Predict Major Haemorrhage 489occurrs.2e7 Arteriovenous malformations (AVMs), the most
aggressive and difficult to treat of the CVMs, are always
present at birth and grow with the patient. Their treatment
is tailored, involving multidisciplinary teams8 and a combi-
nation of endovascular therapies and surgery. This
approach is not evidenced based.
Surgical Techniques in Management of Vascular
Malformations
Feeding vessels ligation has been performed in the past on
AVMs but this has led to a rapid development of collateral
vessels,making future treatments difficult.9e13 The previous
studies on AVMs suggested that a cure is expected when the
whole lesion is removed13,14 or the ‘nidus’ is destroyed.14,15
Well-demarcated lesions may be removed by surgical
excision. Patients with life/limb-threatening complications
of AVMs, or with severe symptoms where surgical excision is
not feasible, may benefit from debulking surgery (partial
removal of the lesion), without necessarily developing
recurrences.16 Although debulking is controversial, it may
correct severe symptoms,17e21 and is a major surgery with
significant risks of bleeding/associated complications.
Published data1e3,22 have suggested that debulking is not
conceptually good, unless warranted, to control serious
complications. Earlier authors believed that simple debulk-
ing will only stimulate the diffuse infiltrating lesion to
re-grow (classified as ‘extratruncular’ lesion in the Hamburg
classification) because these lesions may represent remnant
embryonic tissue and possess mesenchymal cell character-
istics and re-grow when stimulated by debulking. There is no
scientific data to support the embryonic nature of CVM
tissue. Similarly, other authors found that partial excisions
do not imply worsening symptoms or recurrences.16
Compartmentalisation is another surgical option in
selected cases.23 This involves ‘over sewing’ the AVM
vasculature and inducing thrombosis. This is a mechanism
of feeding artery ligation and may indicate its liability to
recurrence, but its outcomes are poorly documented.
Haemorrhage During Surgery for Vascular
Malformation
Surgery on CVMs is associated with major haemorrhage,
because these lesions are composed of abnormal blood
vessels. Consumptive coagulopathy with thrombocytopenia
has been described24,25 in large venous malformations. The
major haemorrhage during surgery on CVMs and the associ-
ated major transfusion can further alter the coagulation.
There are no reports of death with CVM surgery but mortality
associated with surgery in the presence of major haemor-
rhage varies in the literature between 0.1% and 20%.26
According to the classification introduced by the American
College of Surgeons for the ATLS programme in 1997,27 hae-
morrhage greater than 40% (2 l) corresponds to severe hae-
morrhage (grade IV). There are studies28 which considered
major haemorrhageduringelective surgeryblood loss greater
than 1 l. Major intra-operative haemorrhage is one of the
main reasons why surgeons avoid operative management of
CVMs even though patients’ life/limb-threatening compli-
cations or severe symptoms may be significantly improved.Endovascular Techniques in Management of
Vascular Malformations
Endovascular techniques have been increasingly employed
as developed. Advances in endovascular equipments allow
safe supra-selective catheterisation and embolisation of
feeding vessels of high-flow lesions, aiming to induce
localised vascular thrombosis.12 The flow of AVMs can be
reduced by embolisation, but this may be short-lived or
palliative in long term.14,29e31 These techniques are used in
the treatment of CVMs, when feasible. They are especially
important when the risk of bleeding associated with surgery
is too high, the location of the lesion prevents a surgical
excision. Percutaneous sclerotherapy is accepted as inde-
pendent therapy for vascular malformations.14 Embolisa-
tion of venous malformations has disappointing results but
percutaneous sclerotherapy may be effective.32 Repeated
courses of sclerotherapy can clinically improve venous
malformations.33 This technique can be used as an adjuvant
therapy to surgery. Preoperative embolisation decreases
operative haemorrhage.13,15,34 Re-canalisation/recurrence
of the lesion limits these therapies.
The major change on the strategy to CVM management is
the realisation of the harm caused by the embolisation of
feeding vessels. It is now condemned since all the extra-
truncular CVM lesions may be stimulated by embolisation of
the feeding arteries, and these techniques are employed on
symptomatic lesions only.
In this series we investigated preoperative factors for
predicting major haemorrhage at surgery and proposed an
algorithm for the surgical management of CVMs.
Materials and Methods
During a 15-year period (1992-2006), 73 procedures were
performed at a university hospital by a single surgeon (NJS)
on 41 consecutive patients with symptomatic CVMs. Surgery
was indicated for severe pain or potential life/limb-
threatening complications such as ulceration, bleeding,
ischaemia, mass pressure effect, functional impairment
and congestive cardiac failure. All cases operated were
symptomatic after repetitive endovascular treatment or
were unsuitable for endovascular management.
Details of the protocols for interventional radiology
procedures performed in our unit have been described in
the previously published work.35
Surgery was performed on diffuse, infiltrative lesions in
62% of cases and, on well-demarcated lesions in 36% of
cases. All lesions involved intramuscular/soft-tissue
components. Head and neck lesions (19%) involved vital
structures, but we aimed to preserve them during the
operation. In 14 (34%) patients, the vascular lesions
involved bones and/or the deeper vascular stems were
abnormal. The lesions considered in this series are shown in
Figs. 1e6.
The preoperative work-up for this patient population
included magnetic resonance imaging (MRI), angiography,
ultrasound Duplex, computed tomography (CT) scan or
combination of these. We recorded the details of patient
management and assessed the hypothesis that four factors
may be predictive of intra-operative haemorrhage:
Figure 1 a) 64-year-old male with a large borderline high-flow arteriovenous malformation (AVM) involving the left upper arm
(location not suitable for tourniquet application); b) The selective angiography from left profunda brachii showed marked vascular
staining within the mass and some early venous return. The performing radiologist comment was that the rate of the arteriovenous
shunting was not especially rapid; c) Un-enhanced coronal STIR (Phillips 1.5 T) images demonstrates the extent of the lesion, which
involves all the muscles of the upper arm, with some sparing of the most medial aspect of these muscles (arrows).
490 N. Maftei et al.1) type/extent of procedure undertaken (limited proce-
dure/excision or extensive procedure/debulking),
2) anatomical location of lesion and possibility of using
tourniquets proximal to the lesion,
3) flow characteristics of the lesion (‘high’ or ‘low’ flow)
and
4) previous vascular malformation surgery with associated
major haemorrhage.
Further data were collected for surgical blood loss (SBL),
pre- and postoperative platelets, preoperative embolisa-
tion, operation duration, postoperative complications,
follow-up and length of hospital stay. Blood loss greater
than 2 l was considered major haemorrhage in our setting.
These data were collected prospectively from 2003
onwards and retrospectively for patients treated before
2003. Surgical techniques and anaesthesia protocols were
similar for all patients. Anaesthesia was provided by
a consultant anaesthetist experienced with this surgery
(MPG). Cell-saver autologous transfusion was used for
operations performed from 2003 onwards. For the purposes
of presentation all interventions were divided into two
groups: the minor haemorrhage group where the SBL was
less than 2 l and the major haemorrhage group where SBL
was greater than 2 l. The major haemorrhage hospitalprotocol was activated 24 h in advance of surgery for each
patient deemed at risk of major haemorrhage by using
these four risk factors (which were subsequently statisti-
cally analysed for their significance).
Statistical analysis
Analyses were performed on data obtained from 73 CVMs
operations undertaken in 41 patients using the Stata 8
statistical software. Data were analysed according to a pre-
defined statistical analysis plan. SBL data were assessed for
approximation to the normal distribution using normal
plots. To determine whether four risk parameters (type and
extent of surgery performed, location of the vascular lesion
with emphasis on tourniquet feasibility, type of flow and
previous surgery with major haemorrhage) were related to
SBL, non-parametric ManneWhitney U tests were used and
then linear regression of the logarithmic transformed SBL
data was used to adjust for potential confounding. Log-
transformed SBL data were used as SBL was found to be
strongly positively skewed. Transformation of the data only
improved the distribution marginally. No other trans-
formations were found to improve the distribution. A
further regression analysis was performed on logarithmic
SBL with postoperative platelets adjusted for preoperative
Figure 2 MRI chest (Philips 1.5 T) of a 22-year-old male
showing the extent of a complex AVM, which involves the right
thoracic wall and right loin, causing compressive effect. The
fat suppressed coronal breath-hold (FFE/M2D) images (a) and
(b) demonstrate multiple tortuous vessels (see flow voids-
arrows) within in chest wall, extending sub-diaphragmatically
and their association with kypho-scoliosis.
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methods in all regression models and age- and sex-adjusted
models were also performed to assess potential
confounding.
Results
Patient demographics and vascular malformations
management
Eleven (27%) patients were referred to the performing
surgeon by an interventional radiologist, 16 (39%) patients
by surgeons, 12 (29%) by other doctors and two (5%) pre-
sented as an emergency. All patients were operated aftertheir multidisciplinary assessment, except emergency
cases. Fifteen of eighteen procedures in patients with high-
flow lesions were suitable for preoperative embolisation.
Four cases had multiple sessions of embolisation. The
purpose of embolisation was to decrease haemorrhage
during surgery, and it was performed 24e72 h preopera-
tively. Five of all 18 procedures on high-flow lesions resul-
ted in major haemorrhage, with three cases having had
preoperative embolisation (15, 13 and 2 l blood loss). The
rest 13 procedures on high-flow lesions had preoperative
embolisation and did not result in major haemorrhage.
Patient baseline characteristics, surgical management
and postoperative short-term complications are shown in
Table 1.
Surgery was undertaken on 47(64%) venous malforma-
tions, 18 (25%) AVMs, one (1%) lymphatic malformation and
seven (10%) haemo-lymphatic malformations. MRI scan was
performed in 24 (58%) patients. In eight (19%) patients,
angiography was performed in addition to MRI. Fourteen
(34%) patients with high-flow lesions had angiography as
a single investigation. Ultrasound Duplex was performed in
four (10%) patients (in three as a sole investigation) and CT
scanning was performed in three patients.
Extracorporeal bypass was necessary on one occasion.
Tourniquet use proximal to the lesion was not necessary at
the time of surgery. Its use may have not been technically
feasible for the whole duration of long procedures. In short-
term, no patients suffered deterioration of symptoms as
a result of surgery. One patient had a cardiac arrest at the
end of an uneventful operation, but the patient was
successfully resuscitated with no subsequent morbidity.
Two deaths were recorded amongst all 73 operations per-
formed (3%). One patient died of a pneumothorax of
unknown cause during surgery. The second patient suffered
end-stage AVM complications with airway and upper gastro-
intestinal obstruction.
In this series of patients, massive haemorrhage, blood
products transfusions and clotting alterations in the major
haemorrhage group did not lead to prolonged hospital stay
when compared to the minor haemorrhage group (median
hospital stay of 9 days in both groups). Forty-six (63%) cases
had a yearly follow-up, 25 (34%) had open appointments, 11
(15%) had follow-up for at least 1 year (seven cases for 1 year,
six cases for 2 years, two cases for 3 years and 10 cases
between 4 and 10 years). The complications noted after 1
year were as follws: two cases of further ulceration, two
cases of minor local recurrence, one case of exacerbation
during pregnancy at 2 years after debulking, one case ofmild
enlargement and two cases of persistent pain. Further
intervention was required only for the cases with ulceration.Major blood loss during surgery on 73 vascular
malformations and their preoperative transfusion
arrangements
Major blood loss (>2 l) was recorded in 16 (22%) of 73
procedures performed on 11(15%) patients. The amount of
blood loss in the major haemorrhage group varied between
2 l and 25 l. For 12 (75%) of these cases, more than 6 units of
packed red cells were cross-matched preoperatively, as
well as additional blood factors and platelets.
Figure 3 a) 58-year-old female with a thoraco-abdominal (location not suitable for tourniquet application) low-flow vascular
malformation of the left chest/abdominal wall with evidence of previous surgery and remnant vascular lesion with changes within
the skin and subcutaneous fat (arrows); b) Axial STIR through the abdomen (Philips 1.5 T) demonstrating the extension of the
vascular malformation to the abdominal wall with nodular protrusions into the abdominal cavity (arrow); c) Clinical picture of the
same patient demonstrating the final operative result after multiple debulking interventions.
Figure 4 a) Femoral angiography of a very extensive high-flow arteriovenous malformation involving left medial thigh in
a 22-year-old female with recurrent ulcerations and bleeding from overlying skin. The AVM nidus (arrows) is deriving its supply
mostly from branches of the profunda femoris and anterior division of the left internal iliac artery. The performing radiologist
reported extremely rapid arteriovenous shunting into dilated veins, which communicate with the superficial femoral vein. This
patient had multiple femoral embolisations for a period of 4 years until the age of 24, when she had the first debulking operation; b)
Clinical picture of the high-flow AVM with intramuscular and soft tissue components described in a), obtained following the first
debulking operation (patient of 24-years-old); c) Clinical picture of the same patient, obtained following the second debulking
operation (patient of 25-years-old) showing that most lesion was removed.
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Figure 5 a) 30-years-old woman who presented with a large left thigh AVM. Coronal STIR images (Philips 1.5 T) through the lower
extremity showed an extensive left thigh low-flow vascular malformation, which is involving the vastus lateralis and the superficial
fat overlying the lateral and posterior aspect of the thigh. Vastus medialis appeared un-involved; b) Clinical picture of the vascular
malformation described in a), following a limited debulking operation at the lower part of the lesion (arrow) (patient of 31-years-
old). c) Clinical picture of the same lesion, following a third debulking operation (patient of 33-years-old).
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Using four hypothetic risk factors to anticipate major hae-
morrhage from the total number of 73 consecutive CVMs
procedures performed over a 15-year period, we have
anticipated major haemorrhage in all 16 procedures
resulting in major haemorrhage. (Table 2). There was
evidence to suggest an association between SBL and the
type of operation, proximal vascular malformation unsuit-
able for application of a tourniquet and lesions with major
haemorrhage on previous CVMs interventions. There was
little evidence to suggest that the flow characteristics of
the lesion (‘high’ or ‘low’ flow) were associated with SBL.
The SBL data were highly positively skewed with a median
of 100 (range: 50e25 000). The logarithmic transformation
of the data only improved the distribution marginally
(median log (SBL)Z 4.6 (range: 3.9e10.1)). The ManneWhitney U test showed a significant association between
SBL and operation type (pZ 0.005), previous major
haemorrhage (pZ 0.002) and some borderline evidence
that SBL might relate to tourniquet suitability (pZ 0.094)
(Table 2). Similar results were generated from the linear
regression models of log (SBL) and the same three variables
with associations remaining significant when adjusted for
age, sex and all other risk factors. The tourniquet variable
is of borderline significance, but this may relate to the
power of the study. High-flow lesions did not appear to
be associated with major blood loss (pZ 0.288).
Perioperative platelet alterations and hospital stay
Pre- and postoperative platelet measurements and the
differences between them were found to be normally
distributed. The mean number of preoperative platelets
Figure 6 35-year-old male with a right cranio-facial low-flow
vascular malformation extending behind the nasopharynx and
causing marked deviation of the oropharynx and larynx.
Enhanced axial computer tomography image (Siemens, Emotion
Due 16) at the level of C2, demonstrates the malformation
crossing the midline and deviating the oropharynx to the left,
with multiple dilated small vessels extending throughout the
whole of the pharynx.
494 N. Maftei et al.was 250 (SDZ 70) 109 and the mean number of post-
operative platelets was 171 (SDZ 80) 109. There was
a negative association between SBL and the postoperative
platelet count, once adjusted for preoperative measure-
ments (regression coefficient of e 0.017 (95% CI: 0.009 to
0.025), p< 0.0001). High blood loss was related to low
postoperative platelet count, and this association remained
when adjusted for age and sex (p< 0.0001). The length of
hospital stay was not associated with the SBL. The median
(interquartile range) for the duration of hospital stay in
days was 9 (5e17) for the minor haemorrhage and 10 (6e17)
for the major haemorrhage group.
Algorithm for vascular malformation management
Combining the results emerged from this study with our
approach to CVMs, a flow diagram has been compiled to
guide management for vascular malformation. This is based
on a single-centre experience and would require validation.
Discussion
Our experience of 73 procedures for vascular malformation
lesions has indicated that three preoperative risk assess-
ment parameters may help in anticipating major haemor-
rhage during surgery on CVMs. We have hypothesised that
four risk factors would be predictive because high-flow
lesions have been regarded as the most difficult to treat,
and we therefore anticipated that flow type may be
important in predicting major haemorrhage. Analysis of our
data only generated evidence for three risk factors:1) previous vascular malformation surgery with major
haemorrhage (pZ 0.041),
2) debulking surgery (pZ 0.006) and
3) lesion not suitable for tourniquet use (pZ 0.093).
These three risk factors may provide a useful guide in
the preoperative assessment of vascular malformations. We
have preoperatively assessed all 73 cases in this study
guided by four hypothetic risk factors for major haemor-
rhage and overestimated the number of procedures pre-
dicted to result in major SBL at 22%. This provided a safe
environment for all patients undergoing this high-risk
surgery. As a result of the analysis, three predictive factors
for major surgical haemorrhage were produced and were
100% accurate.
The difference between the average times of the oper-
ations in the two groups (4.5 h in the major haemorrhage
group vs. 2.4 h in the minor haemorrhage group) is
explained by the technical difficulties associated with
debulking in patients with previous surgery. In the major
haemorrhage group all 16 (100%) procedures represented by
debulking were performed in 13 cases on patients with
previous debulking. In the minor haemorrhage group of 57
cases, only eight (14%) debulking procedures were per-
formed on such patients. Although the patients in the minor
haemorrhage group spent a similar time in the hospital
postoperatively, this is because all patients had drains
inserted intra-operatively. It is important for the type of
surgery performed to highlight the young average age of
patients of 32 years. Healthy young individuals are able to
tolerate a ‘massive bleeding’ episode, and it is recognised
that they could vasoconstrict intensely in repose to
haemorrhage being able to maintain almost normal
haemodynamic parameters for haemorrhages up to 2 l.27
Intra-operative, transfusions of red blood cells (RBCs),
fresh-frozen plasma (FFP), cryoprecipitate and platelets
were used. The literature reported improved clinical and
operative outcome with transfusion.36 The use of cell-saver
proved essential during surgery on CVMs.
Postoperative platelet counts in this study confirmed the
association between major haemorrhage during surgery,
and low postoperative platelet counts. It is important to act
accordingly with transfusion on recording low operative
platelet counts during surgery.
Both compartmentalisation and excision were not
related to major haemorrhage and were associated with
fewer complications. The complications from vascular
malformation surgery were minor, mainly wound compli-
cations. No patient required major reconstruction of
subsequent defects as a result of surgery. Two patients
referred to our centre had independent endovascular
therapy to intramuscular low-flow lesions and developed
fibrosis, contracture of the affected muscles and loss of
function. Whilst surgically inaccessible and/or intolerable
lesions may be treated with endovascular therapy despite
anticipated muscular contraction, we have noted that
surgical removal of such lesions followed by physiotherapy
led to almost full recovery of the affected muscles.
To highlight the limitations of this study we recognise
that defining a scoring system for preoperative assessment
of vascular malformations may prove useful and thus could
be tested using a randomised trial. Due to the low
Table 1 Patient and operation baseline characteristics.
Characteristics Results
Sex (% male, % female) 25(34%), 48(66%) procedures
14(34%), 27(66%) patients
Age (years) Mean (þ/SD) 32.2(þ/e14.5)
Location of vascular lesion (% of procedures) Upper limb e 21(29%)
Lower limb e 28(38%)
Head and neck e 14(19%)
Trunk e 3(4%)
Trunk and limbs e 7(10%)
Type of operation performed (% of procedures) Debulking e 45(62%)
Excision e 26(36%)
Compartmentalisation e 2(2%)
Flow characteristics of lesion (% of procedures) High-flow e 18(25%)
Low-flow e 55(75%)
Suitability for tourniquet (% of procedures) 42(58%)
Lesions with previous surgery resulting in major haemorrhage (% of procedures) 11(15%)
Symptoms (% of procedures with symptom) Bleeding e 15(21%)
Ulceration/gangrene e 10(14%)
Mass pressure effect e 4(5%)
Functional impairment e 31(42%)
Cardiomegaly e 6(8%)
Severe pain e 58(79%)
Combination e 45(62%)
Preoperative embolisation (% of procedures) 3(4%) (>2 l blood loss)
12(16%) (<2 l blood loss)
Operation duration (hours) (mean þ/ SD) 4.5 þ/1.19 (>2 L blood loss)
2.4 þ/ 1.68 (<2 L blood loss)
Postoperativecomplications (% of procedures) Wound infection e 15(21%)
Collection e 9(12%)
Collection requiring evacuation e7(10%)
Nerve injury e 7(10%)
Local oedema (facial lesions) e 5(7%)
Atrial fibrillation e 1(1%)
(reversed to sinus rhythm)
Chest infection e 1(1%)
Persistent pain e 7(10%)
(improved with subsequent surgery)
Death e 2(3%)
Length of hospital stay (days) (median) [IQR] 9 [5e17]
Table 2 Results for analysis of factors associated with surgical blood loss.
Parameter Surgical
blood loss
<2 l NZ 57
Surgical
blood loss
> 2 l NZ 16
p- value Manne
Whitney U testa
Crude coefficient
from linear regressionb
[95%CI], p- value
Adjusted coefficientc
from linear regressionb
[95%CI], p- value
Age (years) Mean SD 30.8 14.0 36.7 15.8 e e e
Sex (% male) 20 (35%) 5 (31%) e e e
Extent of surgery (% extensive) 31 (54%) 16 (100%) 0.005 1.5 [0.6e2.3], 0.001 1.0 [0.3e1.7], 0.006
High/low flow (% high) 13 (23%) 5 (31%) 0.497 0.5 [0.7e1.8], 0.412 0.5 [0.4e1.4], 0.288
Tourniquet (% feasible) 39 (68%) 3 (19%) 0.094 1.2 [0.1e2.3], 0.034 1.0 [0.2e2.1], 0.093
Previous major haemorrhage
(% major haemorrhage)
4 (7%) 7 (44%) 0.002 1.9 [0.6e3.3], 0.007 1.3 [0.1e2.6], 0.041
a ManneWhitney U-test used SBL as non-transformed, continuous variable.
b Regression model of log-transformed (SBL) as SBL was significantly positively skewed.
c Adjusted for age, sex and all other parameters in table.
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496 N. Maftei et al.prevalence and lesion classification, this would represent
a recruitment challenge. Series data such as ours may be
the best available source of information on CVMs. The
diagram outlining our management protocol for vascular
malformations indicates that patients with high-flow lesions
were considered at risk of major haemorrhage regardless of
previous surgery. This study indicates that high-flow lesions
are not as dangerous as predicted as flow type did not
correlate with major haemorrhage in our study. Within the
diagram 1, the established patients with low-flow lesions
imply that this category of lesions requires stage debulkingSymptomatic vascula
Clinical examination and investigate
High flow
Localised* Extensive**
+/- Preoperative EMB
+/- Excision DSx if feasible/further stage DSx
New 
Localised*
Excision***
MANAGEMENT PROTOCOL FOR V
PREDICTIVE OF MAJO
EMB alone
Diagram 1 Major haemorrhage possible when a tourniquet c
regardless of location of lesion; Major haemorrhage unlikely;
asymptomatic lesion for unacceptable cosmetic appearance, **, Co
lesion sclerotherapy is occasionally indicated as a sole treatment osurgery, and, therefore, they are not localised lesions
amenable to excision (Diagram 1).
This study is unique due to the lack of such data in the
literature. Our results indicate that major haemorrhage in
itself may not be a reason to defer/exclude categories of
patients (presenting severe symptoms or life/limb-threat-
ening complications) from vascular malformation surgery as
long as they are managed by multidisciplinary teams in
specialised centres with adequate surgical, anaesthetic and
haematological resources. Treatment is necessary in
complicated CVMs37 and embolisation alone cannotr malformations
 (MRI, +/- angiography) to assess if:
Low flow
patient Establisheddiagnosis, previous DSx 
Extensive**
DSx if
feasible
SBL on previous
DSx > 2L
SBL on previous
DSx < 2L
DSx if
feasible
ASCULAR MALFORMATIONS,
R HAEMORRHAGE
annot be applied proximally; Major haemorrhage possible
DSx, Debulking surgery; SBL, Surgical blood loss; *, Excision in
nservative treatment in asympotomatic lesions; ***, In low flow
r in addition to surgery.
Surgery on Vascular Malformations and How to Predict Major Haemorrhage 497definitively and totally control these lesions.38 CVMs and
especially AVMs remain a difficult condition for any surgeon
or interventional radiologist to treat, and this study
provides guidance for their management, outlined in the
algorithm we have used in our centre for the management
of vascular malformations.
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